An overview of the safety assessment of medicines currently used in the COVID-19 disease treatment-Reference-Cited by-同舟云学术

An overview of the safety assessment of medicines currently used in the COVID-19 disease treatment

Published:2020-10 Issue: Volume:144 Page:111639
ISSN:0278-6915
Container-title:Food and Chemical Toxicology
language:en
Short-container-title:Food and Chemical Toxicology

Author:

Javorac Dragana^ORCID,Grahovac Lazar,Manić Luka,Stojilković Nikola,Anđelković Milena,Bulat Zorica,Đukić - Ćosić Danijela,Curcic Marijana,Djordjevic Aleksandra Buha

Funder

Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja

Publisher

Elsevier BV

Subject

Toxicology,General Medicine,Food Science

Reference72 articles.

1. Plausibility of therapeutic effects of Rho kinase inhibitors against severe acute respiratory syndrome coronavirus 2 (COVID-19);Abedi;Pharm. Res.,2020

2. Bezbednost primene lekova koji se koriste u terapiji HIV infekcije;Anđelković;Arh. Farm. (Belgr.),2016

3. Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial;Arabi;Trials,2018

4. Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial;Arabi;Trials,2020

5. Comparison between multifocal ERG and C-Scan SD-OCT (“en face” OCT) in patients with a suspicion of antimalarial retinal toxicity: preliminary results;Arndt;Doc. Ophthalmol.,2018

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the Mechanism of Qu Du Qiang Fei 1 Hao Fang Formula against Coronavirus Disease 2019 Based on Network Pharmacology Method;World Journal of Traditional Chinese Medicine;2024-02-02

2. Computer Aided Structure-Based Drug Design of Novel SARS-CoV-2 Main Protease Inhibitors: Molecular Docking and Molecular Dynamics Study;Computation;2024-01-20

3. Investigation of the mutated antimicrobial peptides to inhibit ACE2, TMPRSS2 and GRP78 receptors of SARS-CoV-2 and angiotensin II type 1 receptor (AT1R) as well as controlling COVID-19 disease;Journal of Biomolecular Structure and Dynamics;2023-12-18

4. Polypharmacy and the In Silico Prediction of Potential Body Proteins Targeted by These Drugs Among Hospitalized COVID-19 Patients With Cytokine Storm;Cureus;2023-11-15

5. Potency of Xanthone Derivatives from Garcinia mangostana L. for COVID-19 Treatment through Angiotensin-Converting Enzyme 2 and Main Protease Blockade: A Computational Study;Molecules;2023-07-04